Dexmedetomidine In Prevention Of IOP Elevation After Nd:YAG Laser Capsulotomy

Phase 3

• Conditions: Glaucoma secondary to other eye disorders ( posterior YAG laser capsulotomy).; Glaucoma secondary to other eye disorders; H40.5

• Registration Number: IRCT20231008059648N1
• Lead Sponsor: Ardabil University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

History Of Cataract Surgery With IOL Implantation
Opacity of the posterior capsule to the extent that it causes blurring of vision

Exclusion Criteria

Baseline intraocular pressure above 24 mm/Hg
History Of Any Previous Corneal Surgery( Corneal Graft, Keratorefractive Surgery,...)
History Of Glaucoma
Keratoconus
Corneal Edema

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intraocular Pressure Rise. Timepoint: One hour before YAG laser capsulotomy, 0.5, 4 and 24 hours after YAG laser capsulotomy. Method of measurement: Canon Air Puff ( Non Contact) Tonometer.

Secondary Outcome Measures

Name	Time	Method
Blood Pressure. Timepoint: 30 minutes, before and a half, 4 and 24 hours after using eye drops. Method of measurement: Blood pressure manometer.;Heartbeat ( pulse rate ). Timepoint: 30 minutes, before and a half, 4 and 24 hours after using eye drops. Method of measurement: Pulse Oximeter.;Neusea - Vomiting. Timepoint: 30 minutes, before and a half, 4 and 24 hours after using eye drops. Method of measurement: Observation and clinical examination.;Dry mouth. Timepoint: 30 minutes, before and a half, 4 and 24 hours after using eye drops. Method of measurement: Observation and clinical examination.;Red Eye. Timepoint: 30 minutes, before and a half, 4 and 24 hours after using eye drops. Method of measurement: Observation and clinical examination.